Gene · 64005
Papers2,247
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,247
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pushing the boundaries of innovation: the potential of ex vivo organ perfusion from an interdisciplinary point of view. | Front Cardiovasc Med | 2023 | 37900569 | PubTator, text mining | PubMed |
| Identification and In Silico Characterization of a Conserved Peptide on Influenza Hemagglutinin Protein: A New Potential Antigen for Universal Influenza Vaccine Development. | Nanomaterials (Basel) | 2023 | 37887946 | PubTator, text mining | PubMed |
| Molecular Mechanisms behind Conformational Transitions of the Influenza Virus Hemagglutinin Membrane Anchor. | J Phys Chem B | 2023 | 37877534 | PubTator, text mining | PubMed |
| Crystal structures of the DExH-box RNA helicase DHX9. | Acta Crystallogr D Struct Biol | 2023 | 37860960 | PubTator, text mining | PubMed |
| miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A. | Noncoding RNA Res | 2023 | 37860266 | PubTator, text mining | PubMed |
| Correlation of the methylomic signature of smoking during pregnancy with clinical traits in ADHD. | J Psychiatry Neurosci | 2023 | 37857414 | PubTator, text mining | PubMed |
| A new type of convergent paired electrochemical synthesis of sulfonamides under green and catalyst-free conditions. | Sci Rep | 2023 | 37845371 | PubTator, text mining | PubMed |
| The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate. | J Clin Med | 2023 | 37834964 | PubTator, text mining | PubMed |
Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3+ dendritic cells with CD4+ regulatory T cells and CD8+ exhausted T cells: synergistically remodeling of the immunosuppressive microenvironment in cervical cancer and therapeutic implications. | Cancer Commun (Lond) | 2023 | 37794698 | PubTator, text mining | PubMed |
| Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection. | Molecules | 2023 | 37764217 | PubTator, text mining | PubMed |
| Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications. | Front Oncol | 2023 | 37746261 | PubTator, text mining | PubMed |
| Understanding COVID-19 progression with longitudinal peripheral blood mononuclear cell proteomics: Changes in the cellular proteome over time. | iScience | 2023 | 37736053 | PubTator, text mining | PubMed |
| Forecasting influenza hemagglutinin mutations through the lens of anomaly detection. | Sci Rep | 2023 | 37696867 | PubTator, text mining | PubMed |
| Inhibition of influenza a virus infection by natural stilbene piceatannol targeting virus hemagglutinin. | Phytomedicine | 2023 | 37690231 | PubTator, text mining | PubMed |
| Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus. | Front Immunol | 2023 | 37675108 | PubTator, text mining | PubMed |
| An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses. | Emerg Microbes Infect | 2023 | 37671994 | PubTator, text mining | PubMed |
| Mapping antibody footprints using binding profiles. | Cell Rep Methods | 2023 | 37671022 | PubTator, text mining | PubMed |
| Nucleic acid-based therapeutics for the treatment of central nervous system disorders. | Front Genet | 2023 | 37662844 | PubTator, text mining | PubMed |
| Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy. | Mol Cancer | 2023 | 37649037 | PubTator, text mining | PubMed |
| Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes. | PLoS Pathog | 2023 | 37639457 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64005/papers?page=5